It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded drugs — not be false or misleading,” contended Pharmaceutical Research and ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

So compounded semaglutide is sold in a vial with a separate syringe. Compounding drugs isn’t a new practice. But due to the soaring demand for these weight loss drugs, it’s now a mainstream phenomenon ...

Although the ad does not identify the medication, Hims & Hers offers compounded versions of the weight-loss drug semaglutide, which was developed by Novo Nordisk and is typically sold under the ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Furhman highlighted that year-to-date (YTD) web traffic for Hims Hers Health has jumped by 51% compared to the same period last year. This surge in online interest is consistent with industry patterns ...